Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Human IL-22 receptor-targeted small protein antagonist suppress murine DSS-induced colitis.

Autor: Kuchař M; Laboratory of Ligand Engineering, BIOCEV Research Center, Institute of Biotechnology of the Czech Academy of Sciences, Prumyslova 595, Vestec, 252 50, Czech Republic., Sloupenská K; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, Olomouc, 779 00, Czech Republic., Rašková Kafková L; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, Olomouc, 779 00, Czech Republic. leona.raskova@upol.cz., Groza Y; Laboratory of Ligand Engineering, BIOCEV Research Center, Institute of Biotechnology of the Czech Academy of Sciences, Prumyslova 595, Vestec, 252 50, Czech Republic., Škarda J; Department of Pathology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava, 708 00, Czech Republic., Kosztyu P; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, Olomouc, 779 00, Czech Republic., Hlavničková M; Laboratory of Ligand Engineering, BIOCEV Research Center, Institute of Biotechnology of the Czech Academy of Sciences, Prumyslova 595, Vestec, 252 50, Czech Republic., Mierzwicka JM; Laboratory of Ligand Engineering, BIOCEV Research Center, Institute of Biotechnology of the Czech Academy of Sciences, Prumyslova 595, Vestec, 252 50, Czech Republic., Osička R; Laboratory of Molecular Biology of Bacterial Pathogens, Institute of Microbiology of the Czech Academy of Sciences, Videnska 1083, Prague, 14220, Czech Republic., Petroková H; Laboratory of Ligand Engineering, BIOCEV Research Center, Institute of Biotechnology of the Czech Academy of Sciences, Prumyslova 595, Vestec, 252 50, Czech Republic., Walimbwa SI; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, Olomouc, 779 00, Czech Republic., Bharadwaj S; Laboratory of Ligand Engineering, BIOCEV Research Center, Institute of Biotechnology of the Czech Academy of Sciences, Prumyslova 595, Vestec, 252 50, Czech Republic., Černý J; Laboratory of Structural Bioinformatics of Proteins, BIOCEV Research Center, Institute of Biotechnology of the Czech Academy of Sciences, Prumyslova 595, Vestec, 252 50, Czech Republic., Raška M; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hnevotinska 3, Olomouc, 779 00, Czech Republic., Malý P; Laboratory of Ligand Engineering, BIOCEV Research Center, Institute of Biotechnology of the Czech Academy of Sciences, Prumyslova 595, Vestec, 252 50, Czech Republic. petr.maly@ibt.cas.cz.

Publikováno v: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Oct 01; Vol. 22 (1), pp. 469. Date of Electronic Publication: 2024 Oct 01.

The role of stathmin expression in the differential diagnosis, prognosis, and potential treatment of ovarian sex cord-stromal tumors.

Autor: Šafanda A; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, Prague 2, 12800, Czech Republic., Kendall Bártů M; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, Prague 2, 12800, Czech Republic., Michálková R; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, Prague 2, 12800, Czech Republic., Švajdler M; Šikl's Department of Pathology, The Faculty of Medicine, Faculty Hospital in Pilsen, Charles University, Pilsen, Czech Republic., Shatokhina T; Department of Oncological Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Laco J; The Fingerland Department of Pathology, Charles University Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Hradec Králové, Czech Republic., Matěj R; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, Prague 2, 12800, Czech Republic.; Department of Pathology, Charles University 3rd Faculty of Medicine, University Hospital Královské Vinohrady, Prague, 10034, Czech Republic.; Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University, Thomayer University Hospital, Prague, Czech Republic., Méhes G; Department of Pathology, Faculty of Medicine, University of Debrecen, Debrecen, 4032, Hungary., Drozenová J; Department of Pathology, Charles University 3rd Faculty of Medicine, University Hospital Královské Vinohrady, Prague, 10034, Czech Republic., Hausnerová J; Department of Pathology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic., Špůrková Z; Department of Pathology, Bulovka University Hospital, Prague, Czech Republic., Škarda J; Department of Pathology, University Hospital Ostrava and Faculty of Medicine University of Ostrava, Ostrava, Czech Republic., Hácová M; Department of Pathology, The Regional Hospital Pardubice, Pardubice, Czech Republic., Náležinská M; Division of Gynecologic Oncology, Department of Surgical Oncology, Masaryk Memorial Cancer Institute and Medical Faculty of Masaryk University, Brno, Czech Republic., Dundr P; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, Prague 2, 12800, Czech Republic., Němejcová K; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Studničkova 2, Prague 2, 12800, Czech Republic. Kristyna.Nemejcova@vfn.cz.

Publikováno v: Diagnostic pathology [Diagn Pathol] 2024 Aug 30; Vol. 19 (1), pp. 118. Date of Electronic Publication: 2024 Aug 30.

Small protein blockers of human IL-6 receptor alpha inhibit proliferation and migration of cancer cells.

Autor: Groza Y; Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prumyslova 595, Vestec, 252 50, Czech Republic., Lacina L; Institute of Anatomy, 1st Faculty of Medicine, Charles University, U Nemocnice 3, Prague 2, 12800, Czech Republic. lukas.lacina@lf1.cuni.cz.; Department of Dermatovenerology, 1st Faculty of Medicine, Charles University, U Nemocnice 2, Prague 2, 12000, Czech Republic. lukas.lacina@lf1.cuni.cz., Kuchař M; Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prumyslova 595, Vestec, 252 50, Czech Republic., Rašková Kafková L; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hněvotínská 3, Olomouc, 779 00, Czech Republic., Zachová K; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hněvotínská 3, Olomouc, 779 00, Czech Republic., Janoušková O; Centre of Nanomaterials and Biotechnologies, University of J. E. Purkyně in Ústí nad Labem, Pasteurova 3632/15, Ústí nad Labem, 400 96, Czech Republic., Osička R; Laboratory of Molecular Biology of Bacterial Pathogens, Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague, 14220, Czech Republic., Černý J; Laboratory of Structural Bioinformatics of Proteins, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prumyslova 595, Vestec, 252 50, Czech Republic., Petroková H; Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prumyslova 595, Vestec, 252 50, Czech Republic., Mierzwicka JM; Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prumyslova 595, Vestec, 252 50, Czech Republic., Panova N; Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prumyslova 595, Vestec, 252 50, Czech Republic., Kosztyu P; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hněvotínská 3, Olomouc, 779 00, Czech Republic., Sloupenská K; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hněvotínská 3, Olomouc, 779 00, Czech Republic., Malý J; Centre of Nanomaterials and Biotechnologies, University of J. E. Purkyně in Ústí nad Labem, Pasteurova 3632/15, Ústí nad Labem, 400 96, Czech Republic., Škarda J; Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Hněvotínská 3, Olomouc, 779 00, Czech Republic., Raška M; Department of Immunology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Hněvotínská 3, Olomouc, 779 00, Czech Republic., Smetana K Jr; Institute of Anatomy, 1st Faculty of Medicine, Charles University, U Nemocnice 3, Prague 2, 12800, Czech Republic., Malý P; Laboratory of Ligand Engineering, Institute of Biotechnology of the Czech Academy of Sciences, BIOCEV Research Center, Prumyslova 595, Vestec, 252 50, Czech Republic. petr.maly@ibt.cas.cz.

Publikováno v: Cell communication and signaling : CCS [Cell Commun Signal] 2024 May 07; Vol. 22 (1), pp. 261. Date of Electronic Publication: 2024 May 07.

Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms.

Autor: Ferencz B; Department of Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary.; National Koranyi Institute of Pulmonology, Budapest, Hungary., Török K; Department of Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary.; National Koranyi Institute of Pulmonology, Budapest, Hungary., Pipek O; Department of Physics of Complex Systems, Eotvos Lorand University, Budapest, Hungary., Fillinger J; National Koranyi Institute of Pulmonology, Budapest, Hungary., Csende K; Department of Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary., Lantos A; National Koranyi Institute of Pulmonology, Budapest, Hungary., Černeková R; Department of Pulmonary Diseases and Tuberculosis, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Mitták M; Surgical Clinic, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Škarda J; Medical Faculty, Institute of Clinical and Molecular Pathology, Palacky University Olomouc, Olomouc, Czech Republic.; Department of Pathology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Delongová P; Department of Pathology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Megyesfalvi E; Department of Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary.; Department of Clinical Pharmacology, National Institute of Oncology, Chest and Abdominal Tumors Chemotherapy 'B', Budapest, Hungary., Schelch K; Department of Thoracic Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.; Center for Cancer Research, Medical University of Vienna, Vienna, Austria., Lang C; Department of Thoracic Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.; Division of Pulmonology, Department of Medicine II, Medical University of Vienna, Vienna, Austria., Solta A; Department of Thoracic Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Boettiger K; Department of Thoracic Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Brcic L; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria., Lindenmann J; Division of Thoracic and Hyperbaric Surgery, Department of Surgery, Medical University of Graz, Graz, Austria., Rényi-Vámos F; Department of Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary.; National Koranyi Institute of Pulmonology, Budapest, Hungary.; National Institute of Oncology and National Tumor Biology Laboratory, Budapest, Hungary., Aigner C; Department of Thoracic Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Berta J; National Koranyi Institute of Pulmonology, Budapest, Hungary. berta.judit@koranyi.hu., Megyesfalvi Z; Department of Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary.; National Koranyi Institute of Pulmonology, Budapest, Hungary.; Department of Thoracic Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Döme B; Department of Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary. balazs.dome@meduniwien.ac.at.; National Koranyi Institute of Pulmonology, Budapest, Hungary. balazs.dome@meduniwien.ac.at.; Department of Thoracic Surgery, Comprehensive Cancer Center Vienna, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. balazs.dome@meduniwien.ac.at.; Department of Translational Medicine, Lund University, Lund, Sweden. balazs.dome@meduniwien.ac.at.

Publikováno v: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 May 02; Vol. 73 (6), pp. 114. Date of Electronic Publication: 2024 May 02.